Evidence map›Paper›PMID 36741900›Full record

ArticleFrontiers in microbiology2022

Novel dithiocarbamate derivatives are effective copper-dependent antimicrobials against

Sanjay V Menghani, Yamil Sanchez-Rosario, Chansorena Pok, Renshuai Liu, Feng Gao, Henrik O'Brien, Miranda J Neubert, Klariza Ochoa, Meredythe Durckel, Riley D Hellinger and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. mSphere · 2026
    Article
  3. Review
  4. Article
  5. The promise of copper ionophores as antimicrobials.Current opinion in microbiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Sanjay V MenghaniDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Yamil Sanchez-RosarioDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Chansorena PokDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Renshuai LiuDepartment of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, United States.
Feng GaoDepartment of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, United States.
Henrik O'BrienDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Miranda J NeubertDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Klariza OchoaDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Meredythe DurckelDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Riley D HellingerDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Nadia HackettDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
Wei WangDepartment of Pharmacology and Toxicology, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ, United States.
Michael D L JohnsonDepartment of Immunobiology, University of Arizona College of Medicine - Tucson, Tucson, AZ, United States.
University of Arizona · USRush University · US

Funding

University of Arizona's Initiative for Maximizing Student Development (IMSD)T32GM139779 · NIGMS · UNIVERSITY OF ARIZONA · PI FRANS E TAX · 2022 to 2026
$2.9M
Copper Chelating Compounds as Novel Antimicrobial ClassF30GM139246 · NIGMS · UNIVERSITY OF ARIZONA · PI MENGHANI, SANJAY VIJAY · 2021 to 2022
$82k
NIGMS NIH HHS F30 GM139246NIGMS NIH HHS T32 GM139779
6 · The paper itself

Abstract

Despite the availability of several vaccines against multiple disease-causing strains of

Indexed as

animal modelantimicrobialcopperdithiocarbamatesICP-OESStreptococcus

Identifiers

PMID36741900
PMCPMC9894897
OpenAlexW4317513129

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.